相关实验视频
Updated: Jul 12, 2025

13:00
Studying Wnt Signaling During Patterning of Conducting Airways
Published on: October 16, 2016
7.4K
稳定的COPD患者的下气中的骨形态蛋白及其对手
Antonino Di Stefano1, Umberto Rosani2, Stefano Levra3
1Divisione di Pneumologia e Laboratorio di Citoimmunopatologia dell'Apparato Cardio Respiratorio, Istituti Clinici Scientifici Maugeri, IRCCS, 28010 Veruno, Italy.
Biology
|October 27, 2023
概括
在慢性阻塞性肺病 (COPD) 肺部观察到骨形态蛋白 (BMP) 和它们的抗体CRIM1和chordin的不平衡. 这可能会影响COPD患者的呼吸道改造和修复.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 骨形态蛋白 (BMPs) 和抗体对组织发育和恒温至关重要.
- 这些通路的失调与各种器官病理有关.
研究的目的:
- 研究稳定慢性阻塞性肺病 (COPD) 中BMP及其对手的转录和蛋白质表达.
主要方法:
- 在COPD患者和对照组的支气管活检和肺瘤中检查了BMP和抗剂,使用免疫组织化学和转录组分析.
- 在体外用BMP4蛋白刺激16HBE细胞.
主要成果:
- 增加了COPD患者的支气管上皮质和自身膜中的CRIM1和chordin.
- 在COPD患者的支气管上皮质中减少BMP4表达.
- 降低了COPD患者的膜巨细胞和细胞中的CRIM1和chordin.
- 在体外,BMP4治疗降低了支气管上皮细胞的增殖.
结论:
- 在稳定的COPD肺部中,BMP蛋白及其对手之间存在不平衡.
- 这种不平衡可能会导致呼吸道重塑和COPD中受损的再生反应.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Management Using Bronchodilators and Corticosteroids
217
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
217
Drugs Used in Lower Respiratory Disorders: Overview
458
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
458
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
COPD: Pathogenesis and Clinical Features
305
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
305
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K

